What does CUSIP 02043Q957 represent in this 13F holders report?

CUSIP 02043Q957 is the security identifier for 02043Q957 - ALNYLAM PHARMACEUTICALS INC - COM - Put used to aggregate holder disclosures.

How many institutions held 02043Q957 - ALNYLAM PHARMACEUTICALS INC - COM - Put in Q4 2022?

No institutional holders were reported for 02043Q957 - ALNYLAM PHARMACEUTICALS INC - COM - Put in Q4 2022; review adjacent reporting periods for trend context.

ALNYLAM PHARMACEUTICALS INC - COM - Put

CUSIP: 02043Q957

Q4 2022 13F Holders as of 31 Dec 2022

Type / Class: Equity / COM
Total 13F shares: 0
Share change: -100
Total reported value: $0
Price per share: $237.65
Number of holders: 0
Value change: -$93,000
Number of sells: 1

Quarterly Holders Quick Answers

What is CUSIP 02043Q957?
CUSIP 02043Q957 identifies 02043Q957 - ALNYLAM PHARMACEUTICALS INC - COM - Put in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Related Filing Research

Latest 13F filings for newly reported positions.
Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
Latest 10-Q/10-K reports for financial context tied to this issuer.
Recent insider transactions for executive and insider activity.
SEC investors directory and top value investors for manager drilldown.
Back to full security ownership history.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2023
Previous quarter: Q3 2022

Recent filing periods for CUSIP 02043Q957:

Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024

ALNYLAM PHARMACEUTICALS INC - COM - Put

Q4 2022 13F Holders as of 31 Dec 2022

Quarterly Holders Quick Answers

Related Filing Research

Explore More Reporting Periods

There are no holders of ALNYLAM PHARMACEUTICALS INC - COM - Put as of Q4 2022.